vimarsana.com
Home
Live Updates
TREMFYA® (guselkumab) Real-World Data Analyses Show Greater Treatment Persistence Than IL-17s in Both Bio-naïve and Bio-experienced Patients Living With Moderate to Severe Plaque Psoriasis : vimarsana.com
TREMFYA® (guselkumab) Real-World Data Analyses Show Greater Treatment Persistence Than IL-17s in Both Bio-naïve and Bio-experienced Patients Living With Moderate to Severe Plaque Psoriasis
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data, showing that initiation of TREMFYA® (guselkumab) was...
Related Keywords
Japan
,
Spring House
,
British Columbia
,
Canada
,
United States
,
Horsham
,
Saskatchewan
,
Americans
,
American
,
Canadian
,
Craig Stoltz
,
Dermatol Venereol
,
Lloyd Miller
,
Steven Feldman
,
Thompson Jr
,
Janssen Biotech Inc
,
Ibm
,
Janssen Research Development
,
Janssen Pharmaceutical Companies
,
Janssen Pharmaceutical Companies Of Johnson
,
Wake Forest University School Of Medicine
,
American Academy Of Dermatology
,
Everyday Health
,
Janssen Scientific Affairs
,
Marketscan Research Databases
,
National Psoriasis Foundation
,
Japan Pharmaceuticals
,
None Of The Janssen Pharmaceutical Companies
,
Drug Administration
,
Exchange Commission
,
Companies Of Johnson
,
European Medicines Agency
,
Devices Agency
,
Canadian Agency For Drugs Technologies In Health
,
Johnson
,
Annual Meeting
,
New Orleans
,
Scan Research Databases
,
Wake Forest University School
,
Psoriasis Symptoms
,
Signs Diary
,
Psoriasis Area
,
Severity Index
,
Investigator Global Assessment
,
Dermatology Life Quality Index
,
Vice President
,
Immunodermatology Disease Area Stronghold
,
Janssen Research
,
Scan Research
,
Plaque Psoriasis
,
Prescribing Information
,
Medication Guidefor
,
Pharmaceutical Companies
,
Infectious Diseases
,
Janssen Biotech
,
Private Securities Litigation Reform Act
,
Annual Report
,
Note Regarding Forward Looking
,
Quarterly Reports
,
Accessed March
,
Eur Acad Dermatol
,
Guselkumab Compared
,
Specific Body
,
Participants With Moderate
,
Active Comparator
,
Study Evaluating
,
Severe Plaque Type Psoriasis
,
Randomized Withdrawal
,
Last Updated July
,
Medical Devices
,
Tremfya Report
,
Canadian Agency
,
Multicenter Protocol
,
Severely Active Crohn
,
Severely Active Ulcerative
,
Janssen Pharmaceutical Companies Of Johnson Amp
,
vimarsana.com © 2020. All Rights Reserved.